Clinical trial NCT06120933: A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
Official title: A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Hair Health
Hair Loss
Lead sponsor: BrandiZone
Sponsor class: INDUSTRY
Collaborators: name: Citruslabs
First posted: 2023-11-07
Enrollment: 25
Sex: FEMALE
Minimum age (years): 30
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: This clinical trial aims to investigate the effectiveness of two Vitamins Revive hair supplements in promoting hair growth, reducing hair loss, and improving overall hair health. The products under assessment are Hair Nutra Growth and Hair Nutra Boost. The trial will assess the efficacy of the products to induce better hair growth, reduction in hair loss and shedding, increased hair thickness and fullness, and improvement in hair appearance and vitality over a 12-week testing period. Participants will complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12. Participants will also provide photos of their hair at Baseline, Week 4, Week 8, and Week 12.


Eligibility criteria: Inclusion Criteria:

* Women Aged 30+ Self-reported issues with hair growth, shedding, and thinning Generally healthy - don't live with any uncontrolled chronic disease Must be willing to stop taking any other hair growth supplements or biotin supplements for the duration of the trial In the last three months, has not introduced any new supplements or medications to target hair growth, hair loss, or hair health Individuals must agree to refrain from dyeing their hair in the target interest areas until the study is complete Willing and able to take high-quality photographs of their hairline

Exclusion Criteria:

* Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders Anyone with known severe allergic reactions Anyone with a known allergy to any of the ingredients Anyone currently using a hair growth supplement Anyone currently using biotin Anyone with scalp or hair diseases including but not limited to alopecia areata (a hair loss disorder leading to patchy bald spots on the head) Women who are pregnant, breastfeeding, or attempting to become pregnant Unwilling to follow the study protocol

Primary outcomes:
measure: Changes in self-reported rate of hair growth. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
measure: Changes in self-reported rate of hair loss. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
measure: Changes in hair shedding. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
Secondary outcomes:
measure: Changes in participant-percieved overall hair health. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
Other outcomes:
measure: Changes in hair thickness. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
measure: Changes in hair shine. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
measure: Changes in hair softness. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
measure: Changes in hair vitality. [Timeframe: Baseline to Week 12]
timeFrame: 12 weeks
Locations:
city: Santa Monica
country: United States
facility: Citruslabs
state: California
Study officials:
References: